JeffreyLouisSugarmanMD
Dermatology • Santa Rosa, CADermatologic Surgery, Pediatric Dermatology
Physician
Dr. Sugarman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2725 Mendocino Ave
Santa Rosa, CA 95403Phone+1 707-545-4537Fax+1 707-545-6726
Education & Training
University of California (San Francisco)Residency, Dermatology, 1999 - 2002
University of WashingtonResidency, Pediatrics, 1996 - 1999
University of California San Diego School of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 1999 - 2025
UT State Medical License 2018 - 2020
WA State Medical License 1996 - 1999- American Board of Dermatology Dermatology
- American Board of Dermatology Pediatric Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2011-2013
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis Start of enrollment: 2006 Dec 01
- Systemic Therapies for Pediatric Atopic Dermatitis Start of enrollment: 2011 Oct 01
- A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis Start of enrollment: 2013 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsPsoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in childrenJennifer J Parker, Jeffrey L Sugarman, Nanette B. Silverberg, Mercedes E. Gonzalez, Michele L Ramien
Pediatric Dermatology. 2021-10-14 - 98 citationsThe Objective Severity Assessment of Atopic Dermatitis Score: An Objective Measure Using Permeability Barrier Function and Stratum Corneum Hydration With Computer-Assi...Jeffrey L Sugarman, Joachim W. Fluhr, Ashley J. Fowler, Thomas Bruckner, Thomas L. Diepgen
Archives of Dermatology. 2003-11-01 - 7 citationsClues to primary vismodegib resistance lie in histology and genetics.Qisi Sun, Lihi Atzmony, Theodore Zaki, Albert Peng, Jeffrey L Sugarman
Journal of Clinical Pathology. 2020-03-26
Press Mentions
Advances in Pediatric Eczema TreatmentJanuary 3rd, 2020
Sol-Gel Technologies Hosting Analyst & Investor DayJuly 25th, 2019
Luma Therapeutics Announces Positive Clinical Data for the Illuvinate System, a New in-Home Treatment for PsoriasisMarch 6th, 2019- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
